Clinical Trial: Rivaroxaban in Pediatric Patients With DVT

U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07618988) titled 'Rivaroxaban in Pediatric Patients With DVT' on May 26.

Brief Summary: Prospective interventional randomized controlled trial to assess safety and efficacy of rivaroxaban in pediatric patients with acute deep venous thrombosis.

Study Start Date: Aug. 03, 2024

Study Type: INTERVENTIONAL

Condition: Pediatric Venous Thromboembolism

Intervention: DRUG: Rivaroxaban

Patients allocated to Rivaroxaban arm: after 5 to 9 days of therapy with low molecular weight heparin (LMWH), patients will receive body weight-adjusted 20-mg equivalent doses with an age-appropriate serving of fluid given with or shortly after a meal.

Crushed Rivaroxaba...